The Effect of Medical Treatment on Voice Quality in Allergic Rhinitis
Indian Journal of Otolaryngology and Head and Neck Surgery, cilt.65, sa.SUPPL2, ss.426-430, 2013 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 65 Sayı: SUPPL2
- Basım Tarihi: 2013
- Doi Numarası: 10.1007/s12070-013-0639-5
- Dergi Adı: Indian Journal of Otolaryngology and Head and Neck Surgery
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.426-430
- Anahtar Kelimeler: Allergic rhinitis, Total nasal symptom score, Voice handicap index, Acoustic voice analysis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
To evaluate the change in the voice quality of patients with allergic rhinitis (AR) after medical treatment. The study enrolled 69 subjects: 39 with high serum-specific IgE levels to inhalant allergens as the study group and 30 healthy individuals as controls. All patients were evaluated using the total nasal symptom score (TNSS) and voice handicap index-10 (VHI-10) and then underwent an acoustic voice analysis. After 1 month of treatment with mometasone furoate nasal spray (two 50-μg puffs in each nostril once daily) and desloratadine (5-mg tablet once daily), the patients repeated the surveys and acoustic voice analysis. The results before and after treatment were compared. The TNSS and VHI-10 scores decreased significantly after treatment (p < 0.01). After treatment, the acoustic analysis parameters improved significantly and were similar to the control group, and the maximum phonation time increased significantly (p < 0.05). The voice quality of patients with AR is improved with medical treatment. © 2013 Association of Otolaryngologists of India.